More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...
About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback